Blood Cancer Clinical Trials & Research at Providence Medical Group
Chronic lymphocytic leukemia and multiple myeloma, blood cancers, represent
a large group of different malignancies. This group includes cancers of
the bone marrow, blood, and lymphatic system, which includes lymph nodes,
lymphatic vessels, tonsils, thymus, spleen, and digestive tract lymphoid
tissue. Leukemia and myeloma, which start in the bone marrow, and lymphoma,
which starts in the lymphatic system, are the most common types of blood
cancer. What causes these cancers is not known.
Providence Medical Group is currently enrolling patients for the following
blood cancer clinical trials at this time:
Study for participants with previously untreated Chronic Lymphocytic Leukemia
(Janssen Tailor)
Treatment agent: Ibrutinib treatment regimens
Physician: Dr Jarrod Holmes
Study Coordinator: Melissa Ulrich //
melissa.ulrich@providence.org // 707-521-3830
Study Resources:
Study Details | A Study to Customize Ibrutinib Treatment Regimens for Participants
With Previously Untreated Chronic Lymphocytic Leukemia | ClinicalTrials.gov
Sponsor: Janssen
Location: Providence Cancer Center, Santa Rosa, CA
An Open-Label, Multiple-Dose, Dose-Escalation Study to Investigate the
Safety, Pharmacokinetics, and Pharmacodynamics of VMD-928 in Subjects
with Solid Tumors or Lymphoma